Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Center for Pain & Stress Research is a Canadian healthcare and medical-device company that develops and commercializes microcurrent neuromodulation products and treatment protocols for pain and stress management. The company is best known for the Dolphin Neurostim device and its associated Microcurrent Point Stimulation (MPS) Therapy, which are marketed for use in chronic pain, scar release, vagal stimulation, and related rehabilitation applications. In addition to selling devices and kits for clinic and home use, CPSR provides practitioner education through online and in-person training courses and certification programs. Its business appears to center on commercial medical-device sales, protocol development, and clinician training rather than a traditional drug-development pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Center for Pain & Stress Research.